Page last updated: 2024-08-21

oxazoles and iloprost

oxazoles has been researched along with iloprost in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (77.78)	18.2507
2000's	2 (22.22)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brassard, CL; Buchanan, JO; Gougoutas, JZ; Malley, MF; Martin, SW; Meanwell, NA; Romine, JL; Rosenfeld, MJ; Trehan, AK; Wright, JJ	1
Brassard, CL; Buchanan, JO; Federici, ME; Fleming, JS; Gamberdella, M; Hartl, KS; Meanwell, NA; Rosenfeld, MJ; Trehan, AK; Wright, JJ	1
Wise, H	2
Brassard, CL; Federici, ME; Meanwell, NA; Romine, J; Seiler, SM	1
Chan, HW; Ho, JK; Jones, RL; Lam, WL; Qian, YM; Wise, H; Wong, HN; Yim, AP	1
Chow, KB; Wise, H	1
Chow, KB; Wise, H; Wong, YH	1
Krause, W; Krüger, U; Muschick, P	1

Trials

1 trial(s) available for oxazoles and iloprost

Article	Year
Use of near-infrared reflection spectroscopy to study the effects of X-ray contrast media on renal tolerance in rats: effects of a prostacyclin analogue and of phosphodiesterase inhibitors. Investigative radiology, 2002, Volume: 37, Issue:12 Topics: Animals; Contrast Media; Diatrizoate; Hemoglobins; Iloprost; Iohexol; Kidney Cortex; Male; Oxazoles; Oxygen; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Rolipram; Spectroscopy, Near-Infrared; Triiodobenzoic Acids; Vasodilator Agents	2002

Article

Year

Use of near-infrared reflection spectroscopy to study the effects of X-ray contrast media on renal tolerance in rats: effects of a prostacyclin analogue and of phosphodiesterase inhibitors.

Investigative radiology, 2002, Volume: 37, Issue:12

Topics: Animals; Contrast Media; Diatrizoate; Hemoglobins; Iloprost; Iohexol; Kidney Cortex; Male; Oxazoles; Oxygen; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Rolipram; Spectroscopy, Near-Infrared; Triiodobenzoic Acids; Vasodilator Agents

2002

Other Studies

8 other study(ies) available for oxazoles and iloprost

Article	Year
Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid. Journal of medicinal chemistry, 1993, Nov-26, Volume: 36, Issue:24 Topics: Acetates; Adenosine Diphosphate; Binding, Competitive; Crystallization; Epoprostenol; Humans; Hydrogen Bonding; Iloprost; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship	1993
Non-prostanoid prostacyclin mimetics. 6. Derivatives of 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified beta-to the oxazole ring. Drug design and discovery, 1994, Volume: 11, Issue:1 Topics: Cell Membrane; Humans; Iloprost; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Structure-Activity Relationship	1994
The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function. Prostaglandins, leukotrienes, and essential fatty acids, 1996, Volume: 54, Issue:5 Topics: Acetates; Animals; Calcium; Cell Aggregation; Cyclic AMP; Drug Design; Epoprostenol; Glyburide; Iloprost; Imidazoles; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxazoles; Phenoxyacetates; Phosphodiesterase Inhibitors; Prostaglandins, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin	1996
[3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding. Prostaglandins, 1997, Volume: 53, Issue:1 Topics: Acetates; Adenylyl Cyclases; Animals; Binding, Competitive; Cell Membrane; Cyclic AMP; Epoprostenol; GTP Phosphohydrolases; Humans; Iloprost; Imidazoles; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Protein Kinases; Rabbits; Rats	1997
Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery. Journal of cardiovascular pharmacology, 1997, Volume: 29, Issue:4 Topics: Acetates; Aged; Cardiovascular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Fatty Acids; Humans; Iloprost; Imidazoles; Indoles; Middle Aged; Muscle, Smooth, Vascular; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Prostaglandins, Synthetic; Pulmonary Artery; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship; Vasoconstrictor Agents; Vasodilator Agents	1997
The effect of prostacyclin mimetics on neutrophil function. Advances in experimental medicine and biology, 1997, Volume: 407 Topics: Acetates; Animals; Cell Aggregation; Cyclic AMP; Epoprostenol; Iloprost; Imidazoles; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxazoles; Peritoneal Cavity; Phenoxyacetates; Pyrrolidinones; Rats; Rolipram; Second Messenger Systems; Sulfonamides	1997
The effect of non-prostanoid prostacyclin mimetics on cyclic AMP production by neuronal SK-N-SH cells. Advances in experimental medicine and biology, 1997, Volume: 433 Topics: Acetates; Cell Line; Cyclic AMP; Epoprostenol; Humans; Iloprost; Imidazoles; Kinetics; Neuroblastoma; Neurons; Oxazoles; Phenoxyacetates	1997
Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics. British journal of pharmacology, 2001, Volume: 134, Issue:7 Topics: Acetates; Adenylyl Cyclases; Alprostadil; Animals; Cell Survival; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Iloprost; Imidazoles; Inositol Phosphates; Oxazoles; Phenoxyacetates; Pyridines; Receptors, Epoprostenol; Receptors, Prostaglandin; Transfection; Tritium; Type C Phospholipases	2001